Francesca Wanda Rossi

Plain English
This study looked at the relationship between Epstein-Barr virus (EBV) infection and two conditions: multiple sclerosis (MS) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Researchers found that almost all MS patients (97.3%) and most MOGAD patients (96.4%) had EBV antibodies, but the levels of certain antibodies were significantly higher in MS patients. This difference may indicate that EBV plays a distinct role in how these two diseases develop, which could influence treatment approaches. Who this helps: This research benefits doctors and patients dealing with MS and MOGAD by providing insights into the role of EBV in these conditions.

Plain English
This research studied severe asthma, which affects about 10% of people with asthma, and focused on the role of eosinophils, a type of white blood cell that can cause inflammation. The findings highlight the importance of using specific tests, like measuring eosinophil levels and other biomarkers, to categorize asthma patients for better-targeted treatments. By doing this, doctors can choose the most effective therapies, potentially leading to fewer asthma attacks and less reliance on steroids. Who this helps: This benefits asthma patients who need more effective treatment options.

Plain English
This research focused on finding the best source of stem cells to help treat patients with Systemic Sclerosis, a disease that causes skin hardening and other serious health issues. The study discovered that stem cells from Wharton's jelly (a part of umbilical cord tissue) are particularly effective in promoting healing in skin cells, outperforming other sources like bone marrow and adipose tissue by providing more growth factors. This is important because finding effective treatments can improve quality of life for those suffering from this challenging condition. Who this helps: This benefits patients with Systemic Sclerosis.

Plain English
This research paper looked at how systemic lupus erythematosus (SLE), an autoimmune disease, can affect the lungs, which is often not recognized. The study found that lung problems are common in SLE patients and can worsen their overall health, increasing the risk of severe complications. By identifying and treating these lung issues early, doctors can help prevent permanent damage and improve patients' quality of life. Who this helps: This helps patients with systemic lupus erythematosus and their doctors by emphasizing the importance of monitoring lung health.

Plain English
The LUNET Project is creating a national registry for patients with systemic lupus erythematosus (SLE), a complicated autoimmune disease that can affect various body parts. This registry will collect real-world data on patient experiences and treatment outcomes to improve understanding and management of SLE. It aims to provide long-term insights that can help tailor treatments to individual needs and inform healthcare strategies. Who this helps: Patients with systemic lupus erythematosus and their healthcare providers.

Plain English
This study looked at three substances in the blood—uPA, PAI-1, and suPAR— to see if they could help assess the severity of systemic sclerosis (SSc), a condition that affects the skin and organs. Researchers found that patients with SSc had lower levels of uPA (about 3,226 pg/ml) and higher levels of PAI-1 (95.30 ng/ml) and suPAR (around 2.52 ng/ml to 3.83 ng/ml), which were linked to the disease's symptoms. This matters because suPAR, especially when tested with one specific method, showed strong potential to help track how severe the disease is. Who this helps: Patients with systemic sclerosis and their doctors.

Plain English
This study looked at how certain immune cells in patients with Orofacial Granulomatosis (OFG) respond to bacteria and other triggers. The researchers found that immune cells from OFG patients released more harmful substances, like TNF-α and other inflammatory markers, compared to healthy individuals. Specifically, OFG patients had higher levels of proteins linked to inflammation, including three specific molecules (MMP-9, MPO, and TNF-α) in their blood. Understanding these differences is important for finding better treatments for OFG. Who this helps: This research benefits patients with Orofacial Granulomatosis by identifying potential new treatment approaches.

Plain English
This study looked at how certain blood cells called eosinophils behave in patients with seasonal allergies who also have bronchial asthma and related conditions. Researchers found that most patients had mild allergy responses tied to allergen exposure, but a group with a "persistent" pattern of eosinophils experienced severe allergies that weren't linked to pollen. Patients with this severe condition improved significantly when treated with benralizumab, an allergy medication. Who this helps: This helps patients with severe allergies, particularly those with bronchial asthma and chronic sinus issues.

Plain English
This study focused on how certain receptors in skin cells called N-formyl peptide receptors (FPRs) interact with another protein, uPAR, in people with systemic sclerosis (SSc), a serious autoimmune disease that causes skin and organ stiffness. The researchers discovered that SSc skin cells grow more quickly than healthy cells due to this interaction, with SSc fibroblasts showing higher growth rates. Importantly, a new synthetic drug was found to reduce the excessive growth of these SSc skin cells, indicating potential for new treatments targeting this process. Who this helps: This benefits patients with systemic sclerosis by offering new treatment options.

Plain English
This study looked at food allergies, particularly focusing on peach allergies in Southern Italy. Researchers found that food allergies are increasingly common and show significant differences around the world, with serious symptoms linked to allergens like peach proteins. Understanding these differences is crucial for effective treatment and management of food allergies based on where patients live. Who this helps: This information benefits patients with food allergies and their doctors in managing their conditions effectively.

Plain English
The study focused on hypereosinophilic syndrome (HES), a rare condition that affects the body's eosinophils, a type of white blood cell. Researchers found that there are still many challenges in diagnosing HES quickly and effectively, leading to delays in treatment, which can significantly harm patients' quality of life. A major goal of the Italian Society of Allergy, Asthma, and Clinical Immunology is to create a network that will improve knowledge and collaboration among healthcare providers to enhance patient care. Who this helps: This benefits patients with hypereosinophilic syndrome and their doctors.

Plain English
This study examined the role of neutrophils, a type of white blood cell, in patients with psoriatic arthritis (PsA). Researchers found that neutrophils from 31 PsA patients were less active and effective at fighting infections compared to those from 22 healthy individuals. They also discovered that PsA patients had higher levels of certain inflammatory markers in their blood, indicating a more complex immune response associated with the disease. Who this helps: This research benefits patients with psoriatic arthritis by improving understanding of their condition and guiding future treatments.

Plain English
This study looked at the effects of water from Nitrodi's Spring on skin cells that are important for healing wounds. The researchers found that the water boosted the survival and movement of key skin cells called fibroblasts and stimulated the growth of another type of skin cell called keratinocytes. Specifically, Nitrodi's water enhanced the activity of fibroblasts and lowered harmful molecules linked to skin damage, which shows potential for improving skin repair. Who this helps: This helps patients with wounds or skin problems.

Plain English
This study looked at how a type of white blood cell called eosinophils contributes to inflammation in diseases like severe asthma and chronic obstructive pulmonary disease. Researchers found that eosinophils cause damage and persistence of these conditions, making it critical for doctors to identify specific patient characteristics to choose the right treatments. Understanding these differences helps improve treatment strategies, as some patients may respond better to new drugs targeting eosinophils. Who this helps: This helps patients with severe asthma and other eosinophilic airway diseases.

Plain English
This study looked at how effective belimumab is for patients with systemic lupus erythematosus (SLE) who have joint and skin problems. Researchers found that after six months, 46% of patients significantly improved their joint symptoms, and 36% had no skin issues. Belimumab also helped reduce the need for steroids, with 31.6% of patients being completely off steroids by 36 months. Who this helps: This benefits patients with SLE and their doctors by providing an effective treatment option that reduces both symptoms and reliance on steroids.

Plain English
This study looked at calcinosis cutis and calciphylaxis, serious complications that can occur in people with autoimmune diseases like lupus and rheumatoid arthritis. The researchers found that calcinosis cutis often happens in damaged skin and may appear in several autoimmune disorders, while calciphylaxis can lead to dangerous blood clots and vascular issues. Understanding these conditions is important for doctors to provide the right treatment and prevent long-term health problems. Who this helps: This helps patients with autoimmune diseases and their doctors.

Plain English
This study looked at how certain factors from melanoma cells affect a type of white blood cell called neutrophils, which play a key role in inflammation. Researchers found that melanoma cells influenced neutrophils to move, survive, and become activated in ways that were not seen with normal skin cells. Specifically, in patients with advanced melanoma, levels of certain chemicals related to neutrophils were significantly higher compared to healthy individuals, indicating that melanoma cells enhance the activity of these immune cells. Who this helps: This research benefits patients with metastatic melanoma by improving understanding of their immune response.

Plain English
This research looked at the benefits of water from Nitrodi's Spring, a famous spa known for its healing properties. Studies show that Nitrodi's water helps with wound healing and reduces inflammation by promoting cell growth and migration, while also providing protection against oxidative stress. Specifically, it boosts cell viability and has shown anti-inflammatory effects, which are crucial for treating conditions like allergic and autoimmune diseases, as well as age-related skin issues. Who this helps: This helps patients with inflammatory and autoimmune conditions, as well as those dealing with skin aging.

Plain English
This study looked at how bradykinin-mediated angioedema (a condition causing swelling) affects the nervous system, particularly in patients with hereditary angioedema (HAE). It found that patients can suffer from severe headaches, vision issues, and even have symptoms similar to a stroke, alongside higher levels of anxiety and depression. Understanding these symptoms is important because they can greatly impact patients' quality of life and lead to complications in treatment. Who this helps: This helps patients with hereditary angioedema and their doctors in diagnosing and managing their symptoms.

Plain English
Researchers gave 31 patients with hereditary angioedema (a rare condition causing sudden swelling attacks) two doses of the Pfizer COVID-19 vaccine to see if the shots would trigger more attacks or cause problems. While a few patients did have swelling attacks shortly after the first shot, the vaccine did not increase attack frequency overall, and patients' disease control actually improved after vaccination. All vaccinated patients developed protective antibodies against COVID-19 just like healthy people did, confirming the vaccine worked in this population.

Plain English
This study looked at the effects of a specialized Cardio-Oncology unit on cancer patients who also have heart problems in Southern Italy. Among 231 patients, those currently receiving cancer treatment (Type 2) experienced the highest rate of heart-related issues—46.2% compared to only 12.3% in patients not yet treated (Type 1) and 17.9% in those who had completed treatment (Type 3). This group also faced lower survival rates, but they showed improvement in heart function with proper cardiovascular care, highlighting the importance of evaluating heart health before starting cancer treatments. Who this helps: This benefits cancer patients, especially those undergoing treatment who may also have heart problems.

Plain English
This study looked at lung health in patients with primary Sjögren's syndrome (pSS), focusing on how it affects their breathing. Researchers tested 22 patients and found that 94.5% had emphysema, with 81.8% showing reduced lung function in exchange for gases, measured by a specific test (DLCO). This is important because it highlights that lung issues like emphysema can occur even when patients don’t show obvious breathing problems. Who this helps: This helps patients with primary Sjögren's syndrome by providing insights into potential lung complications.

Plain English
This study looked at how chest CT scans can help tell the difference between lung problems caused by systemic sclerosis (SSc) and those caused by COVID-19. Researchers analyzed data from 99 patients, finding that certain CT features like fibrosis in specific areas are linked to SSc-ILD, while signs of consolidation in the lower lobes are more common in COVID-19 cases. This is important because using these CT features can improve accuracy in diagnosing these two conditions and tailor treatments more effectively. Who this helps: Patients suffering from interstitial lung disease related to systemic sclerosis or COVID-19.

Plain English
This study focused on a new scoring system called Predictive Response to Immunotherapy Score (PRIS) to help identify patients who are likely to benefit from allergen immunotherapy (AIT). Researchers evaluated 110 patients with allergic rhinitis (some with asthma) and found that those who received sublingual immunotherapy showed significant improvement in their symptoms after 12 and 24 months. Specifically, PRIS was effective in predicting symptom improvement in all patients, whether they had just rhinitis or also asthma. Who this helps: This helps patients suffering from allergies and asthma, along with their doctors in making treatment decisions.

Plain English
This study focused on how certain enzymes called secreted phospholipases A (sPLAs) affect a type of immune cell known as macrophages, which play a key role in cancer development. Researchers found that two specific types of sPLAs, group IIA and group X, significantly influence the behavior of macrophages involved in cancer, impacting inflammation linked to tumor growth. Understanding how these enzymes interact with immune cells could lead to new ways to predict cancer outcomes and improve cancer treatments. Who this helps: This helps patients and doctors by improving cancer treatment strategies.

Plain English
This study looked at a patient with systemic sclerosis (a serious lung disease) who developed spontaneous pneumomediastinum (air trapped in the chest) after recovering from COVID-19. The patient had a history of smoking and lung issues, which likely contributed to the formation of cysts in the lungs that eventually broke, causing the pneumomediastinum. This finding is important because it shows that doctors should closely examine patients with systemic sclerosis who have respiratory issues after COVID-19, as there may be other underlying complications that need attention. Who this helps: This helps patients with systemic sclerosis and their doctors.

Plain English
Researchers tested whether people with lupus (an autoimmune disease) could safely receive the Pfizer COVID-19 vaccine and whether their bodies would respond to it properly. They tracked 41 lupus patients and 29 people with a different rare condition to compare, measuring antibodies after the first shot and again after the second shot. Both groups developed strong protective antibodies at similar levels, and the vaccine did not trigger lupus flare-ups or make the disease worse.

Plain English
This study looked at soccer players in Italy's second league to understand their use of medications and the potential negative effects (adverse drug reactions) from them. Almost all players (91.8%) used non-steroidal anti-inflammatory drugs (NSAIDs), and 7.4% reported experiencing harmful side effects. These findings highlight that while many players rely on medications for pain relief, they are at risk of serious health issues from these drugs, such as allergic reactions or breathing problems. Who this helps: This information is important for athletes and doctors to manage medication use safely.

Plain English
This research paper examined how immunosuppressive drugs may help treat patients with antiphospholipid syndrome (APS), a condition that leads to blood clots and pregnancy complications. The study found that while there is limited evidence from large studies, some patients with severe cases, like catastrophic antiphospholipid syndrome (which affects about 1% of APS cases), might benefit from these drugs, especially if they have ongoing health problems despite standard treatments. This research is important because it could lead to new treatment options for patients who struggle with blood clots and other related issues. Who this helps: This benefits patients with antiphospholipid syndrome and their doctors.

Plain English
This study looked at the effectiveness of a medication called mepolizumab for treating patients with eosinophilic granulomatosis with polyangiitis (EGPA), a serious condition that affects various body organs. Eight patients took mepolizumab for a year, and results showed a significant drop in disease activity scores, with about a 50% reduction in symptoms related to the disease and asthma, alongside less need for steroids. This is important because it shows that mepolizumab could make a real difference in managing EGPA while reducing reliance on more harmful medications. Who this helps: Patients with severe EGPA and their doctors.

Plain English
This study examined the connection between skin inflammation from psoriasis and the development of psoriatic arthritis (PsA), focusing on how certain areas of affected skin relate to bone damage in the joints. Researchers found that specific skin locations impacted by psoriasis were linked to increased activity of cells that break down bone, indicating a pathway from skin inflammation to joint issues. These findings are important because they help explain how psoriasis can lead to PsA and highlight the role of skin health in joint disease. Who this helps: This helps patients with psoriasis and psoriatic arthritis by improving understanding of their conditions.

Plain English
This study looked at how certain receptors in the immune system, known as formyl peptide receptors (FPRs), are linked to rheumatoid arthritis (RA), a disease that causes painful swelling and can damage joints. Researchers found that FPRs play a role in both increasing and reducing inflammation, depending on the situation. Analyzing data from 90 RA patients, they explored how these receptors relate to the different symptoms and characteristics of the disease. This insight could help develop more targeted treatments for RA symptoms and progression. Who this helps: Patients with rheumatoid arthritis.

Plain English
This study looked at 95 adults with Common Variable Immunodeficiency (CVID), a condition that weakens the immune system. It found that 41% of these patients (39 individuals) had autoimmune issues, with immune thrombocytopenia being the most common (10.5% of patients), followed by arthritis and psoriasis. Recognizing these autoimmune problems early is important to improve patients' lives and reduce serious health complications. Who this helps: This helps patients with CVID and their doctors in diagnosing and managing autoimmune conditions that can arise.

Plain English
This study looked at how well the medication belimumab helps patients with lupus nephritis (a type of kidney problem caused by lupus) in everyday medical settings. Among 91 patients treated with belimumab, 70% saw a significant improvement in their kidney function, and nearly 39% achieved a complete response. Factors like high blood pressure and poor kidney function at the start made it less likely for patients to respond well to the treatment, while certain positive lab results and early improvement made future success more likely. Who this helps: This benefits patients with lupus nephritis, especially those struggling with kidney problems.

Plain English
This study looked at a condition called mastocytosis, where there are too many mast cells (a type of immune cell) in the body, often due to a genetic mutation. Researchers found that patients with mastocytosis had higher levels of certain substances (VEGF-A, ANGPT1, ANGPT2, and VEGF-C) in their blood compared to healthy individuals, and higher levels were linked to more severe symptoms. This matters because understanding these changes in blood levels can help in diagnosing and managing mastocytosis more effectively. Who this helps: This helps patients with mastocytosis and their doctors.

Plain English
This study focuses on a rare condition called Episodic Angioedema with Eosinophilia (Gleich's Syndrome), which causes swelling, itching, weight gain, and fever in episodes that occur every few weeks. Researchers described a case of a 32-year-old woman who had these symptoms and severe eosinophilia, with eosinophil levels rising to as high as 95 x 10 cells/L. Understanding this condition is important because it helps doctors recognize it better and treat it effectively, as there are no established guidelines for diagnosing it yet. Who this helps: This benefits patients suffering from Gleich's Syndrome and their doctors.

Plain English
This study explores how metabolism, immunity, and inflammation are linked in rheumatoid arthritis (RA). Researchers found that the high energy needs of certain immune cells in the joints lead to an accumulation of substances that fuel inflammation. Understanding these connections is crucial because it could lead to new treatments for RA. Who this helps: This helps patients with rheumatoid arthritis.

Plain English
This study looked at how a protein from HIV called gp120 affects immune cells in the lungs, specifically mast cells. Researchers found that within just 30 minutes, gp120 caused these cells to release important chemicals like histamine and, over six hours, led to the production of substances that promote blood vessel growth. This matters because it helps us understand why people with HIV often have ongoing lung issues, potentially guiding better treatments for these patients. Who this helps: This helps patients with HIV and chronic lung diseases.

Plain English
In this study, researchers looked at how effective a new type of dressing—made of polyurethane foam—was when used alongside standard treatments for digital ulcers in patients with scleroderma. They found that using this foam dressing led to a 50% decrease in the number of active ulcers and reduced the time patients spent in the hospital for ulcer-related issues. Additionally, patients reported better quality of life after using the dressing. Who this helps: This research benefits patients with scleroderma who suffer from digital ulcers.

Plain English
Researchers studied how different types of pulmonary hypertension (high blood pressure in the lungs) occur in people with systemic sclerosis, an autoimmune disease that affects the skin and other organs. They found that there are various causes of pulmonary hypertension in these patients, and correctly identifying the specific type is crucial for effective treatment. Proper diagnosis can lead to timely therapies that significantly lower the risk of death, especially since treatments may vary widely based on the specific cause. Who this helps: This helps patients with systemic sclerosis and their doctors by improving treatment options and outcomes.

Plain English
This paper examines how certain molecules called resolvins, which come from omega-3 fatty acids, affect inflammation and fibrosis in a chronic autoimmune disease known as systemic sclerosis (SSc). The research highlights that when there's a problem with how the body resolves inflammation, it can lead to ongoing inflammation and tissue scarring, which are key features of SSc. Understanding the role of resolvins is important because it may lead to better treatments for managing this complex disease. Who this helps: This helps patients with systemic sclerosis and their doctors.

Plain English
This study looked at a type of immune cell called mast cells in the joints of patients with early rheumatoid arthritis (RA) before and after they received standard treatment. Researchers found that after six months of treatment, while inflammation in the joints decreased, about 45% of patients still had high levels of mast cells, which linked them to ongoing inflammation and disease activity. This is important because it shows that even with treatment, some patients may continue to have harmful immune responses, indicating they might need different or additional therapies. Who this helps: This research benefits patients with rheumatoid arthritis and their doctors by highlighting the need for better treatment strategies for those with persistent symptoms.

Plain English
This study looked at how Nitrodi thermal water from a famous spa can help with low-level inflammation and stress-related health issues by using RKO cancer cells in the lab. Researchers found that this water improved cell movement and survival while decreasing a specific condition called protein S-nitrosylation, which is linked to inflammation. These findings support the idea that Nitrodi water can be a useful addition to standard medical treatments. Who this helps: This helps patients dealing with inflammation and stress-related conditions.

Plain English
The study looked at how certain small molecules called microRNAs change in people with common variable immunodeficiency (CVID) after receiving their first treatment with immunoglobulin (Ig). Researchers found five specific microRNAs that were altered after the treatment: four decreased while one, called miR-6742, increased. This is important because understanding these changes may help doctors find new ways to treat CVID and improve patient care. Who this helps: Patients with common variable immunodeficiency and their healthcare providers.